George G Zhanel

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Escherichia Coli

Multidrug Resistant

Pseudomonas Aeruginosa

Antimicrobial Resistance

Top Venues

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Antimicrobial agents and chemotherapy

Journal of clinical microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

John J Schellenberg, Heather J Adam, Melanie R Baxter, James A Karlowsky, Alyssa R Golden, Irene Martin, George G Zhanel
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21. The Journal of antimicrobial chemotherapy (2024)
George G Zhanel, Celine Mansour, Stacey Mikolayanko, Courtney K Lawrence, Sheryl Zelenitsky, Danyel Ramirez, Frank Schweizer, Denice Bay, Heather Adam, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Nina Clark, David Nicolau, Carlo Tascini, James A Karlowsky
Cefepime-Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination. Drugs (2024)
James A Karlowsky, Andrew J Walkty, Melanie R Baxter, Heather J Adam, Philippe R S Lagacé-Wiens, Frank Schweizer, Denice C Bay, Joseph P Lynch, Michael R Mulvey, George G Zhanel
In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019. Microbiology spectrum 10 (4) (2022)
George G Zhanel, Marianna Pozdirca, Alyssa R Golden, Courtney K Lawrence, Sheryl Zelenitsky, Liam Berry, Frank Schweizer, Denice Bay, Heather Adam, Michael A Zhanel, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Kurt Naber, Joseph P Lynch, James A Karlowsky
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Drugs 82 (5) (2022)
Graham W Cox, Brent P Avery, E Jane Parmley, Rebecca J Irwin, Richard J Reid-Smith, Anne E Deckert, Rita L Finley, Danielle Daignault, George G Zhanel, Michael R Mulvey, Amrita Bharat
A One Health Genomic Investigation of Gentamicin Resistance in Escherichia coli from Human and Chicken Sources in Canada, 2014 to 2017. Antimicrobial agents and chemotherapy 66 (10) (2022)
George G Zhanel, Christina Deng, Sheryl Zelenitsky, Courtney K Lawrence, Heather J Adam, Alyssa Golden, Liam Berry, Frank Schweizer, Michael A Zhanel, Neal Irfan, Denice Bay, Philippe Lagacé-Wiens, Andrew Walkty, Lionel Mandell, Joseph P Lynch, James A Karlowsky
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia. Drugs 81 (2) (2021)
James A Karlowsky, Melanie R Baxter, Alyssa R Golden, Heather J Adam, Andrew J Walkty, Philippe R S Lagacé-Wiens, George G Zhanel
Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive Cocci. Journal of clinical microbiology 59 (12) (2021)
George G Zhanel, Michael A Zhanel, Kevin F Boreskie, Joseph P Lynch, James A Karlowsky
Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2021 (2021)
Carmine J Slipski, Taylor R Jamieson-Datzkiw, George G Zhanel, Denice C Bay
Characterization of Proteobacterial Plasmid Integron-Encoded qac Efflux Pump Sequence Diversity and Quaternary Ammonium Compound Antiseptic Selection in Escherichia coli Grown Planktonically and as Biofilms. Antimicrobial agents and chemotherapy 65 (10) (2021)
Walter H B Demczuk, Irene Martin, Averil Griffith, Brigitte Lefebvre, Allison McGeer, Gregory J Tyrrell, George G Zhanel, Julianne V Kus, Linda Hoang, Jessica Minion, Paul Van Caeseele, Rita Raafat Gad, David Haldane, George Zahariadis, Kristen Mead, Laura Steven, Lori Strudwick, Michael R Mulvey
Linear regression equations to predict β-lactam, macrolide, lincosamide and fluoroquinolone minimum inhibitory concentrations from molecular antimicrobial resistance determinants in Streptococcus pneumoniae. Antimicrobial agents and chemotherapy (2021)
George G Zhanel, Michael A Zhanel, James A Karlowsky
Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2020 (2020)
James A Karlowsky, Philippe R S Lagacé-Wiens, Nancy M Laing, Melanie R Baxter, Heather J Adam, George G Zhanel
Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods. Journal of clinical microbiology 58 (10) (2020)
George G Zhanel, Michael A Zhanel, James A Karlowsky
Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2018 (2018)
George G Zhanel, Michael A Zhanel, James A Karlowsky
Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2018 (2018)
Louise Perrault, Sybil Dahan, Ange Christelle Iliza, Jacques LeLorier, George G Zhanel
Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2017 (2017)